vimarsana.com
Home
Live Updates
Paxlovid Weaker Against Current COVID-19 Variants : vimarsan
Paxlovid Weaker Against Current COVID-19 Variants : vimarsan
Paxlovid Weaker Against Current COVID-19 Variants
A real-world study found that Pfizer's COVID-19 antiviral Paxlovid is now less effective at preventing hospitalization or death in high-risk patients as compared with earlier studies.
Related Keywords
Cleveland Clinic ,
Florida ,
United States ,
,
Bloomberg ,
Medscape Coronavirus Resource Center ,
Coronavirus Resource ,
North Carolina Gillings School ,
Global Public Health ,
Molnupiravir Use ,
Severe Outcomes From Omicron Infections ,
First Oral Antiviral ,
Study Shows ,